Digitalis obscura the use of herbal medicinal remedies using "Digitalis obscura" has lessened to a great degree because of the knowledge of its high toxicity. In ethnoveterinary medicine, the flowering stems of "Digitalis obscura" were traditionally used to promote wound healing and treat toothaches in animals. It is one of twenty-three species traditionally used in Granada to treat trauma or poisoning in animals. All parts of "Digitalis obscura" are poisonous if ingested raw, including the roots and seeds. The most potent parts of the plant are the upper leaves. All foxgloves are highly toxic if eaten because they contain various cardiac glycosides
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug